Pooled expression prevalence rates of carcinoma in situ were at least comparable to (GLUT1 and IGF1R) or higher than (CAIX and CXCR4) invasive carcinoma, albeit based on few studies. This evidence concerns the gene SLC2A1 and in situ carcinoma.